Skip to main content
Clinical Trials/ISRCTN26261491
ISRCTN26261491
Completed
未知

A pilot, randomised single blind study to evaluate the utility and efficacy of neutral argon plasma as a new technology in achieving complete cytoreduction of advanced epithelial ovarian carcinoma - initial feasibility study

Royal Surrey County Hospital NHS Foundation Trust (UK)0 sites150 target enrollmentMay 27, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Surrey County Hospital NHS Foundation Trust (UK)
Enrollment
150
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 27, 2014
End Date
December 30, 2017
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Royal Surrey County Hospital NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Imaging\+/\- Clinical \+/\- laparoscopic e/o pelvic mass and metastatic disease (FIGO III/IV disease) at presentation
  • 2\. Confirmation of malignancy on histological/cytological criteria
  • 3\. All women aged 18 or over with newly diagnosed FIGO stage III to Stage IV EOC undergoing surgical treatment
  • 4\. All women fit to undergo treatment
  • 5\. No synchronous malignancy likely to interfere with comparisons
  • 6\. Written and informed patient consent

Exclusion Criteria

  • 1\. Patient choice
  • 2\. Patient unfit for any treatment modality
  • 3\. Patients who are medically unfit for surgery and would only be suitable for chemotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials